TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
23,842
|
35,034
|
24,540 |
| Financial expenses |
1
|
5
|
240 |
| Earnings before taxes |
-32,407
|
-40,540
|
-40,433 |
| EBITDA |
-29,204
|
-36,621
|
-36,412 |
| Total assets |
23,499
|
29,419
|
29,629 |
| Current assets |
15,598
|
17,989
|
15,147 |
| Current liabilities |
10,802
|
9,602
|
17,776 |
| Equity capital |
12,697
|
19,817
|
11,853 |
| - share capital |
90
|
93
|
93 |
| Employees (average) |
41
|
46
|
47 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
54.0%
|
67.4%
|
40.0% |
| Turnover per employee |
582
|
762
|
522 |
| Profit as a percentage of turnover |
-135.9%
|
-115.7%
|
-164.8% |
| Return on assets (ROA) |
-137.9%
|
-137.8%
|
-135.7% |
| Current ratio |
144.4%
|
187.3%
|
85.2% |
| Return on equity (ROE) |
-255.2%
|
-204.6%
|
-341.1% |
| Change turnover |
-10,033
|
10,367
|
-38,415 |
| Change turnover % |
-30%
|
42%
|
-61% |
| Chg. No. of employees |
-5
|
-1
|
6 |
| Chg. No. of employees % |
-11%
|
-2%
|
15% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.